Skip to content

Integrated Treatment of Marijuana Abuse for HIV+ Youth

Integrated Treatment of Alcohol and/or Marijuana Abuse for HIV-Infected Youth - Phase I

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00683488
Enrollment
46
Registered
2008-05-23
Start date
2008-04-30
Completion date
2011-04-30
Last updated
2017-03-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Keywords

Substance Abuse, Adolescent community reinforcement approach, Adolescent Risk Behavior Assessment, Child and Adolescent Services Assessment, Cognitive behavioral therapy, Cognitive Therapy Rating Scale, Individual behavior therapy, Individual cognitive problem solving, Motivational enhancement therapy, HIV-Positive Youth With Substance Abuse, Complementary Therapies

Brief summary

This is an exploratory study that will adapt and test a combined cognitive behavioral treatment and contingency management intervention for alcohol and/or marijuana abuse for use in HIV-infected adolescents.

Interventions

BEHAVIORALFocus Group

Focus group using and collecting feedback on the CBT/CM intervention.

BEHAVIORALFirst Intervention Trial

Intervention will comprise of approximately 15 weekly sessions. * Exit interviews at the end of each session will assess acceptability, feasibility, and relevance of the intervention. * Quantitative assessment (ACASI) pre and post intervention will document immediate changes in substance use, sexual risk, and adherence to medical care. * Qualitative feedback from interviews with mental health providers and study coordinators will address acceptability and feasibility.

BEHAVIORALIntervention Trial 2

Evaluations/assessments will be similar to those involved for the first intervention trial. Study participants will return for a follow-up visit 3 months after the last intervention session to complete the ACASI.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
National Institute of Mental Health (NIMH)
CollaboratorNIH
University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
16 Years to 24 Years
Healthy volunteers
No

Inclusion criteria

* Adolescents between the ages of 16-24 years (inclusive) at the time of informed consent/assent as determined by medical record review or verbal verification from referring professional * HIV-infected and aware of their status as documented by medical record review or verbal verification from referring professional * Receives services at one of the three participating ATN clinic site or their community partners * A score of 2 or greater on the CRAFFT indicating possible alcohol or marijuana use problem or abuse * Alcohol and/or Marijuana Use or Abuse Disorder as indicated by the SSPQ-X * Appropriate for an outpatient or intensive outpatient level of care in accordance with the American Academy of Child and Adolescent Psychiatry practice parameters as decided by site mental health provider in consultation with Drs. Brown and Esposito-Smythers * English-speaking * Ability and willingness to provide informed consent/assent for study participation * Satisfactorily understands the nature of the study and the informed consent process as documented by the Consent Form Comprehension Assessment Questionnaire

Exclusion criteria

* Presence of serious psychiatric symptoms (e.g., active hallucinations, thought disorder) * Visibly distraught (e.g., suicidal, homicidal, exhibiting violent behavior) * Intoxicated or under the influence of alcohol or other substances at the time of study entry

Design outcomes

Primary

MeasureTime frame
To adapt a developmentally appropriate CBT/CM intervention for alcohol and/or marijuana abuse for HIV+ youth, relevant to the context of chronic medical care, emotion dysregulation due to frequent co-morbid psychiatric disorders and sexual risk behavior.2 years
To evaluate the acceptability, feasibility, and effectiveness of the CBT/CM intervention for alcohol and/or marijuana abuse, adherence to medical care, emotion regulation, and safer sexual behavior.2 years

Secondary

MeasureTime frame
To revise the CBT/CM intervention based on information obtained in Phase 1 (this protocol), prepare for Phase 2 (to be supported by NIH), and disseminate the treatment manual to the ATN sites.2 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026